Pages that link to "Q40878004"
Jump to navigation
Jump to search
The following pages link to Candidal vulvovaginitis. (Q40878004):
Displaying 47 items.
- Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush) (Q24243315) (← links)
- Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes (Q24800992) (← links)
- Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England (Q30806797) (← links)
- Clinical and cost considerations in the pharmacotherapy of vulvovaginal candidiasis (Q33572331) (← links)
- Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital (Q33666272) (← links)
- Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital (Q33839533) (← links)
- Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women. (Q33934940) (← links)
- Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida (Q33935810) (← links)
- Vaginal candidosis: epidemiological and etiological factors (Q34105393) (← links)
- Recurrent vaginal candidiasis changes in etiopathogenical patterns (Q34105397) (← links)
- Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis (Q34229783) (← links)
- Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus (Q34407893) (← links)
- Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented (Q35115653) (← links)
- Risk factors for candida infection of the genital tract in the tropics (Q35207143) (← links)
- Epidemiology of vulvar vestibulitis syndrome: an exploratory case-control study (Q35562613) (← links)
- Antibiotic-associated Vulvovaginal Candidiasis (Q35594792) (← links)
- Cytolytic vaginosis: misdiagnosed as candidal vaginitis (Q35614522) (← links)
- Prevalence of cervicovaginal infections during gestation and accuracy of clinical diagnosis (Q35615446) (← links)
- Fluconazole susceptibility and ERG11 gene expression in vaginal candida species isolated from Lagos Nigeria (Q35862713) (← links)
- Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR. (Q36076036) (← links)
- Systemic vs. topical therapy for the treatment of Vulvovaginal Candidiasis (Q36624472) (← links)
- New treatments for vulvovaginal candidiasis (Q36625081) (← links)
- Use of CHROMagar Candida for genital specimens in the diagnostic laboratory (Q37209669) (← links)
- Genetic basis for recurrent vulvo-vaginal candidiasis (Q38077131) (← links)
- Common office problems in pediatric urology and gynecology. (Q39115306) (← links)
- Antifungal agents in the 1990s. Current status and future developments (Q40900121) (← links)
- Treatment of Vaginal Infections: Candidiasis, Bacterial Vaginosis, and Trichomoniasis (Q41710635) (← links)
- A new model of vaginal infection by Candida albicans in rats. (Q43039230) (← links)
- Susceptibility profile of vaginal yeast isolates from Brazil. (Q43705057) (← links)
- Cellular immunity in recurrent vulvovaginal candidiasis. (Q43786085) (← links)
- Ultrastructural imaging of Candida albicans adhesion to rat genital epithelium through scanning and transmission electron microscopy. (Q44662628) (← links)
- Dapagliflozin, a novel, selective SGLT2 inhibitor, improved glycemic control over 2 weeks in patients with type 2 diabetes mellitus (Q46171591) (← links)
- Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans. (Q46571049) (← links)
- Vulvovaginal candidiasis and its related factors in diabetic women (Q46817450) (← links)
- Sexual behavior of women with repeated episodes of vulvovaginal candidiasis (Q51044594) (← links)
- Candida and dysbacteriosis: a cytologic, population-based study of 100,605 asymptomatic women concerning cervical carcinogenesis. (Q53329265) (← links)
- Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern. (Q55340243) (← links)
- Vaginal microbiological flora and sexually transmitted diseases in women with recurrent or current vulvovaginal candidiasis (Q71920318) (← links)
- Prevalence of and risk factors for fungal vaginitis caused by non-albicans species (Q73047485) (← links)
- The relationship of bacterial vaginosis, candida and trichomonas infection to symptomatic vaginitis in postmenopausal women attending a vaginitis clinic (Q73677529) (← links)
- Effect of antibiotic use on the prevalence of symptomatic vulvovaginal candidiasis (Q77893065) (← links)
- Sexually transmitted diseases (Q79182973) (← links)
- Prevalence and exoenzyme secretion by Candida albicans isolates from oral and vaginal mucosas of HIV-infected women (Q80165480) (← links)
- A simplified technique for evaluating the adherence of yeasts to human vaginal epithelial cells (Q80231390) (← links)
- Oncotic colpocytology stained with Harris-Shorr in the observation of vaginal microorganisms (Q81272491) (← links)
- Effect of Ipragliflozin (ASP1941), a Novel Selective Sodium-Dependent Glucose Co-Transporter 2 Inhibitor, on Urinary Glucose Excretion in Healthy Subjects (Q84856868) (← links)
- A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis (Q92689765) (← links)